Chronic Kidney Disease in Adolescent and Adult Patients with Phenylketonuria
Overview
Authors
Affiliations
Objectives: A lifelong phenylalanine-restricted diet with supplementation of a phenylalanine-free amino acid formula is recommended in patients with phenylketonuria (PKU). The effect of a long-term PKU diet on renal function and blood pressure has not been investigated yet.
Design: We analyzed renal function in 67 patients with PKU, aged 15-43 years, by measuring glomerular filtration rate (GFR) and effective renal plasma flow by isotope clearance ((51)Cr-EDTA, (123)J-Hippuran), estimated GFR, blood retention parameters, urinary protein and electrolyte excretion. Renal ultrasound and 24 h ambulatory blood pressure monitoring were performed additionally. Patients were divided into three groups according to their: 1) current diet (CD), i.e., daily protein intake: ICD <0.8 g/kg, IICD 0.8-1.04 g/kg, IIICD >1.04 g/kg; 2) life-long diet time (LDT), i.e., cumulative years of life in which daily protein intake exceeded dietary recommendations: ILDT <15 years, IILDT 15-19 years, IIILDT >19 years.
Results: GFR was decreased in 19 % of the patients. With increasing protein intake, GFR decreased significantly (ICD 111 ml/min; IICD 105 ml/min; IIICD 99 ml/min. ILDT 112 ml/min; IILDT 103 ml/min; IIILDT 99 ml/min). Proteinuria was detected in 31 %, microalbuminuria in 7 %, and hypercalciuria in 23 % of the patients. 23 % of the patients had arterial hypertension, and 41 % revealed a nocturnal non-dipping status.
Conclusions: In patients with PKU on a lifelong diet we could detect impaired renal function in 19 %, proteinuria in 31 %, and arterial hypertension in 23 %. Thus, chronic kidney disease may develop in PKU patients, and routine renal function tests should be performed during long-term follow-up.
Tanacli R, Doeblin P, Faragli A, Hassel J, Stehning C, Plockinger U J Cachexia Sarcopenia Muscle. 2025; 16(1):e13667.
PMID: 39797500 PMC: 11724155. DOI: 10.1002/jcsm.13667.
Fernandes Silva L, Vangipurapu J, Oravilahti A, Laakso M Int J Mol Sci. 2024; 25(18).
PMID: 39337529 PMC: 11432478. DOI: 10.3390/ijms251810044.
Weerd J, van Wegberg A, Boer T, Engelke U, Coene K, Wevers R Metabolites. 2024; 14(9).
PMID: 39330486 PMC: 11434371. DOI: 10.3390/metabo14090479.
Amino Acid Profile Alterations in Phenylketonuria: Implications for Clinical Practice.
Matuszewska E, Matysiak J, Kaluzny L, Walkowiak D, Plewa S, Dus-Zuchowska M Metabolites. 2024; 14(7).
PMID: 39057720 PMC: 11279192. DOI: 10.3390/metabo14070397.
Rocha J, Ahring K, Bausell H, Bilder D, Harding C, Inwood A Nutrients. 2023; 15(18).
PMID: 37764724 PMC: 10536918. DOI: 10.3390/nu15183940.